NCT03375138View on ClinicalTrials.gov

A Study Using Healthy Volunteers Comparing Belatacept Which Has Been Manufactured By 2 Different Processes

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

May 8, 2018

Study Completion Date

April 2, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

belatacept

Specified dose on specified days

Trial Locations (2)

75247

Covance, Inc., Dallas

78744

PPD Austin Clinic, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY